Skip to main content
SpringerLink
Log in

Risk of DVT higher with drospirenone/EE than with norethindrone/EE

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Comparing the risk of deep vein thrombosis of two combined oral contraceptives: Norethindrone/ethinyl estradiol and drospirenone/ethinyl estradiol Heliyon : 18 Feb 2024. Available from: URL: https://doi.org/10.1016/j.heliyon.2024.e26462

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of DVT higher with drospirenone/EE than with norethindrone/EE. Reactions Weekly 1999, 12 (2024). https://doi.org/10.1007/s40278-024-54321-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-54321-6

Search

Navigation